MiNK Therapeutics, Inc. (INKT) Financials

INKT Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 10.4 million 23.1 million
Dec. 31, 2025 14.2 million 28.5 million
Sept. 30, 2025 15.0 million 28.5 million
June 30, 2025 2.5 million 27.7 million

INKT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -1.7 billion 630.4 million
Dec. 31, 2025 -2.1 million 2.7 billion
Sept. 30, 2025 -941350 620585
June 30, 2025 -1.6 million 896552

INKT Net Income

No data available :(

INKT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 9.5 million - -
Dec. 31, 2025 13.4 billion - -
Sept. 30, 2025 14.3 million - -
June 30, 2025 1.7 million - -

INKT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 4.8 million
Dec. 31, 2025 4.3 million
Sept. 30, 2025 4.4 million
June 30, 2025 4.0 million

INKT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 1.2 billion 1.7 billion -
Dec. 31, 2025 3 5.8 billion 6.7 billion -
Sept. 30, 2025 2 1.1 million 1.8 million -
June 30, 2025 - 1.8 million 1.8 million -

INKT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 36066
Dec. 31, 2025 - 38563
Sept. 30, 2025 - 43654
June 30, 2025 - 48763

INKT

Price: $12.14

52 week price:
6.80
76.00

Earnings Per Share: -2.80 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 4128

Market Capitalization: 59.1 million

Links: